SS
CHRS icon

SBI Securities’s Coherus Oncology CHRS Stock Holding History

SBI Securities’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.57K Buy
6,124
+5,435
+789% +$8.87K ﹤0.01% 1915
2026
Q1 		$1.16K Sell
689
-35
-5% -$62 ﹤0.01% 2605
2025
Q4 		$1.03K Sell
724
-1
-0.1% -$1 ﹤0.01% 2634
2025
Q3 		$1.19K Buy
725
+1
+0.1% +$1 ﹤0.01% 2620
2025
Q2 		$529 Sell
724
-3,000
-81% -$2.59K ﹤0.01% 2938
2025
Q1 		$3K Buy
3,724
+2,976
+398% +$3.42K ﹤0.01% 2118
2024
Q4 		$1.03K Buy
+748
New +$839 ﹤0.01% 2596

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

SBI Securities's CHRS Position: Q2 2026 in Review

SBI Securities increased its Coherus Oncology (CHRS) stake by 789% in Q2 2026, buying an estimated $8.87K and bringing the position to 6,124 shares worth $8.57K. The position accounts for ﹤0.01% of the portfolio, ranked #1915.

SBI Securities first reported a position in CHRS in Q4 2024 and has held it in 7 quarters since. 147 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • SBI Securities held 6,124 shares of Coherus Oncology worth $8.57K as of Q2 2026.
  • SBI Securities bought 5,435 Coherus Oncology shares in Q2 2026, an estimated $8.87K.
  • Coherus Oncology made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1915 holding.
  • SBI Securities first reported a position in Coherus Oncology in Q4 2024 and has held it in 7 quarters since.
  • 147 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.